People
The senior leadership team at Israel-based BrainStorm Cell Therapeutics, Inc. has changed with the appointments of two seasoned industry veterans Joseph Petroziello and Susan Ward.
A group of Takeda Pharmaceutical shareholders’ bid to halt the acquisition of Dublin-based Shire failed to gain traction.
Nearly four years after first forging a research collaboration, AbbVie and Calico, Google’s life science company, have extended that 10-year pact with another $1 billion pledge to develop therapies associated with age-related diseases, including neurodegeneration and cancer.
Roivant Sciences, Vivek Ramaswamy’s umbrella company for his family of “Vants,” announced major restructuring that includes a cut of 10 percent of staff and reshuffling of leadership.
The week of June 18 to June 22 was bookended by a big hiring announcement in the pharma industry. It began with a former Cowen analyst being tapped as chief financial officer of startup Allogene and ended with the retirement announcement of the group worldwide chairman at Johnson & Johnson.
There is another change coming to the senior leadership team at Swiss pharma giant Roche.
As a female chief executive officer in the healthcare industry Karen Zaderej often stands out in a male-dominated industry.
Sunny Balwani intends to fight not only the criminal charges, but is also fighting the charges brought by the SEC.
In January, Berkshire Hathaway, Amazon and JP Morgan Chase announced they were creating a joint healthcare venture. Today, they announced that Atul Gawande will be the chief executive officer.
Eloxx Pharmaceuticals tapped Celgene veteran Neil Belloff as the company’s general counsel and corporate secretary.
PRESS RELEASES